Harvest Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38M Buy
6,571
+58
+0.9% +$19.9K 1.18% 24
2026
Q1
$2.29M Sell
6,513
-180
-3% -$64.2K 1.28% 23
2025
Q4
$2.19M Sell
6,693
-22
-0.3% -$6.98K 1.24% 22
2025
Q3
$1.89M Buy
6,715
+339
+5% +$98.3K 1.11% 32
2025
Q2
$1.78M Buy
6,376
+109
+2% +$30.9K 1.15% 30
2025
Q1
$1.95M Buy
6,267
+11
+0.2% +$3.25K 1.41% 18
2024
Q4
$1.63M Buy
6,256
+30
+0.5% +$8.9K 1.13% 31
2024
Q3
$2.01M Buy
6,226
+14
+0.2% +$4.58K 1.36% 17
2024
Q2
$1.94M Sell
6,212
-137
-2% -$40.2K 1.43% 15
2024
Q1
$1.81M Buy
6,349
+48
+0.8% +$14K 1.35% 19
2023
Q4
$1.81M Sell
6,301
-68
-1% -$18.5K 1.46% 13
2023
Q3
$1.71M Sell
6,369
-102
-2% -$25.5K 1.53% 12
2023
Q2
$1.44M Buy
6,471
+1
+0% +$232 1.23% 26
2023
Q1
$1.56M Buy
6,470
+3
+0% +$736 1.39% 17
2022
Q4
$1.7M Buy
+6,467
New +$1.73M 1.6% 12

Other funds holding AMGN

Harvest Investment Advisors's AMGN Position: Q2 2026 in Review

Harvest Investment Advisors increased its Amgen (AMGN) stake by 0.89% in Q2 2026, buying an estimated $19.9K and bringing the position to 6,571 shares worth $2.38M. The position accounts for 1.18% of the portfolio, ranked #24.

Harvest Investment Advisors first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Harvest Investment Advisors held 6,571 shares of Amgen worth $2.38M as of Q2 2026.
  • Harvest Investment Advisors bought 58 Amgen shares in Q2 2026, an estimated $19.9K.
  • Amgen made up 1.18% of Harvest Investment Advisors's portfolio in Q2 2026, its #24 holding.
  • Harvest Investment Advisors first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Harvest Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.